Following the move from obscurity to superiority worldwide in technology based call centers, India has moved to stake a claim in the lucrative world of vaccine.
Competing with the likes of multi-billion dollar Roche and in just 6-months, a low cost bird flu vaccine.
At a predicted 35 paise retail per dose (US$ 0.65) and with six months protection the $160 million investment appears to have paved the way for bird vaccination instead of eradication.
More on India's own bird flu vaccine at just 35 paise from DailyIndia.com
Subscribe to:
Post Comments (Atom)
1 comment:
We yield to no one, in our admiration of the growth of technology in India.
However, the vaccines recently produced by India as well as by China, are aimed at the CURRENT H5N1 STRAIN and will be of no help, if the virus mutates in to a real human virus strain.
You see, H5N1 is a Bird Flu virus, which is NOT supposed to be killing people.
The new vaccines could well help with the current H5N1 strain, but if the virus mutates in to a human virus, as it did back in 1918, the above mentioned vaccines will not provide any protection against the new strain.
As of today, 143 humans have died of this virus, (that we know of) which is well over 50% of all those who were infected by it.
What is more, the H5N1 virus is now growing at twice the rate of its growth during the last year!
We have today added the "India - Leads with Bird Flu and Call Centers" entry of your blog to The-Best-Bird-Flu-Blogs section of our site.
Hope that you will remain interested in the progress of this potentially devastating virus and that we will have more postings from you.
The-Best-Bird-Flu-Blogs team.
www.birdflubreakingnews.com
Post a Comment